{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:07:04Z","timestamp":1776391624303,"version":"3.51.2"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ajo.2006.01.019","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T08:00:42Z","timestamp":1150012842000},"page":"997-1008.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Management of Ocular Hypertension: A Cost-effectiveness Approach From the Ocular Hypertension Treatment Study"],"prefix":"10.1016","volume":"141","author":[{"given":"Steven M.","family":"Kymes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Philip","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae O.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2006.01.019_bib1","unstructured":"Lighthouse International. New approach to assessing glaucoma risk may help physicians decide who needs treatment: vision connections, 2005. Last accessed: December 15, 2005. Available at: http:\/\/www.visionconnection.org\/Content\/ForProfessionals\/PatientManagement\/DiseaseManagement\/Glaucoma\/default.htm"},{"key":"10.1016\/j.ajo.2006.01.019_bib2","series-title":"Vision problems in the United States","author":"Friedman","year":"2002"},{"key":"10.1016\/j.ajo.2006.01.019_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199111143252004","article-title":"Racial differences in the cause-specific prevalence of blindness in east Baltimore","volume":"325","author":"Sommer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2006.01.019_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oxfordjournals.aje.a113626","article-title":"The epidemiology of open-angle glaucoma","volume":"118","author":"Leske","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2006.01.019_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ophtha.2004.01.025","article-title":"Prevalence of open-angle glaucoma and ocular hypertension in Latinos","volume":"111","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib7","series-title":"Clinical decision making","first-page":"26","article-title":"Practice policies and guidelines","author":"Eddy","year":"1996"},{"key":"10.1016\/j.ajo.2006.01.019_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archopht.122.3.376","article-title":"The Ocular Hypertension Treatment Study","volume":"122","author":"Robin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib10","first-page":"301","article-title":"Glaucoma patients\u2019 assessment of their visual function and quality of life","volume":"99","author":"Jampel","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2006.01.019_bib11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archopht.1997.01100160617016","article-title":"Visual function and quality of life among persons with glaucoma","volume":"115","author":"Parrish","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib12","series-title":"Methods for the economic evaluation of health care programmes","first-page":"305","author":"Drummond","year":"1997"},{"key":"10.1016\/j.ajo.2006.01.019_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The Ocular Hypertension Treatment Study","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","article-title":"A multi-center, retrospective pilot study of resource utilization and costs associated with severity of disease in glaucoma","volume":"124","author":"Lee","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib15","series-title":"Clinical decisions in glaucoma","author":"Hodapp","year":"1993"},{"key":"10.1016\/j.ajo.2006.01.019_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0272989X8300300403","article-title":"The Markov process in medical prognosis","volume":"3","author":"Beck","year":"1983","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajo.2006.01.019_bib17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0161-6420(94)31090-6","article-title":"The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands","volume":"101","author":"Dielemans","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib18","unstructured":"In: Medical Economics Staff, editors. 2005 Drug topics red book. Montvale (NJ): Thomson Medical Economics; 2005."},{"key":"10.1016\/j.ajo.2006.01.019_bib19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.87.10.1201","article-title":"What is the cost of blindness?","volume":"87","author":"Meads","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.282.5387.245","article-title":"Outcomes research","volume":"282","author":"Clancy","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ajo.2006.01.019_bib21","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1097\/00005650-200009002-00024","article-title":"What do utilities measure?","volume":"38","author":"Tsevat","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.ajo.2006.01.019_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archopht.118.1.47","article-title":"Utility values and age-related macular degeneration","volume":"118","author":"Brown","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00061198-200204000-00012","article-title":"Glaucoma patients\u2019 assessment of their visual function and quality of life","volume":"11","author":"Jampel","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2006.01.019_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.ajo.2006.01.019_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bjo.2004.063784\/10.1136\/bjo.2004.063792","article-title":"Value based medicine","volume":"89","author":"Kymes","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.85.3.327","article-title":"Utility values associated with blindness in an adult population","volume":"85","author":"Brown","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What Is the Price of Life and Why Doesn\u2019t It Increase with the Rate of Inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajo.2006.01.019_bib28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMsb032612","article-title":"Medicare coverage for technological innovations","volume":"350","author":"Gillick","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2006.01.019_bib29","series-title":"Cost-effectiveness in health and medicine","first-page":"425","author":"Gold","year":"1996"},{"key":"10.1016\/j.ajo.2006.01.019_bib30","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0161-6420(03)00796-6","article-title":"Cost-utility analysis of cataract surgery in the second eye","volume":"110","author":"Busbee","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on good research practices: modeling studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.ajo.2006.01.019_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajo.2006.01.019_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0161-6420(02)01094-1","article-title":"Risk factors for incident nuclear opacities","volume":"109","author":"Leske","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib35","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajo.2006.01.019_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"10.1016\/j.ajo.2006.01.019_bib37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/archopht.121.7.1070-a","article-title":"Ocular hypertension treatment study results could be misconstrued","volume":"121","author":"Weene","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00061198-200408000-00014","article-title":"A risk calculator to determine the probability of glaucoma","volume":"13","author":"Mansberger","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2006.01.019_bib39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.123.10.1351","article-title":"Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma","volume":"123","author":"Medeiros","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib40","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajo.2004.04.058","article-title":"An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma","volume":"138","author":"Friedman","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archopht.122.6.813","article-title":"The Ocular Hypertension Treatment Study","volume":"122","author":"Higginbotham","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib42","first-page":"89","article-title":"Incidence of open-angle glaucoma","volume":"119","author":"Leske","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0161-6420(02)01040-0","article-title":"Five-year incidence of open-angle glaucoma","volume":"109","author":"Mukesh","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00019053-199915050-00001","article-title":"Pharmacoeconomic evaluation in the real world","volume":"15","author":"Revicki","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ajo.2006.01.019_bib45","series-title":"Clinical epidemiology","author":"Weiss","year":"1996"},{"key":"10.1016\/j.ajo.2006.01.019_bib46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archopht.121.4.540","article-title":"Patient preferences for eye drop characteristics","volume":"121","author":"Jampel","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib47","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0161-6420(03)00408-1","article-title":"Glaucoma and survival","volume":"110","author":"Lee","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archopht.122.5.716","article-title":"Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib49","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0161-6420(03)00799-1","article-title":"Glaucoma and mortality","volume":"110","author":"Leske","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bjo.85.3.322","article-title":"Vision impairment predicts five year mortality","volume":"85","author":"McCarty","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.01.019_bib51","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(98)91133-2","article-title":"The probability of blindness from open-angle glaucoma","volume":"105","author":"Hattenhauer","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.01.019_bib52","series-title":"Method for constructing complete annual US life tables","author":"Anderson","year":"1999"},{"key":"10.1016\/j.ajo.2006.01.019_bib53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archopht.121.1.108","article-title":"Prevention of herpes simplex virus eye disease","volume":"121","author":"Lairson","year":"2003","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:52:49Z","timestamp":1757595169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939406000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0002939406000390"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2006.01.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Ocular Hypertension: A Cost-effectiveness Approach From the Ocular Hypertension Treatment Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2006.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}